India's Pharmaceutical Exports

Country Profile

Brazil

Brazil is one of India's largest pharmaceutical export destinations — $862M in FY 2025–26, with 3.0× growth over the past decade. Medicines accounts for 64% of shipments, with vaccines contributing $44.4M. The compound annual growth rate since FY2015 stands at 10.4%.

🇧🇷 #5 Destination · $862M · 3.0× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$862M
Exports FY2025–26 DGCIS
3.0×
Growth FY2015→2026
2.8%
Share of India Total
#5
Rank Among 178 Markets
10.4%
CAGR FY2015→2026
Brazil is one of India's largest pharmaceutical export destinations — $862M in FY 2025–26, with 3.0× growth over the past decade. Medicines accounts for 64% of shipments, with vaccines contributing $44.4M. The compound annual growth rate since FY2015 stands at 10.4%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $553M (64.2%) Medicine Ingredients $233M (27.1%) Vaccines $44.4M (5.1%) Surgical & Hospital Supplies $26.8M (3.1%) Traditional & Herbal $4.29M (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Brazil in the RBI overseas direct investment dataset (2011–2026).